Theravance Biopharma Inc (TBPH)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 14.65M | 10.42M | 13.75M | 15.69M | 17.57M | 14.5M | 14.26M | 16.87M |
営業利益 | -17.43M | -24.91M | -16.12M | -8.76M | -6.24M | -11.21M | -12.75M | -9.28M |
税引前収入 | -14.26M | -22.48M | -14.19M | -7.58M | -5.02M | -10.4M | -15.22M | -10.05M |
純利益 | -10.36M | -22.09M | -15.65M | -8.95M | -8.51M | -11.66M | -16.53M | -12.7M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -17.43M | -24.91M | -16.12M | -8.76M | -6.24M | -11.21M | -12.75M | -9.28M |
EBITDA | -17.89M | -24.29M | -15.57M | -8.33M | -5.95M | -10.78M | -12.33M | -8.85M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 48.65M | 15.39M | 60.37M | 73.41M | 71.86M | 55.31M | 51.35M | 57.42M |
営業利益 | -180.47M | -260.12M | -227.57M | -218.21M | -229.32M | -153.8M | -91.96M | -56.04M |
税引前収入 | -180.56M | -271.71M | -226.09M | -241.68M | -286.54M | -199.58M | -92.82M | -49.27M |
純利益 | -190.67M | -285.41M | -215.52M | -236.46M | -278.02M | -199.43M | 872.13M | -55.19M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -3.609 | -5.248 | -3.871 | -4.147 | -4.322 | -2.679 | 13.371 | -1.108 |
EBIT | -180.47M | -260.12M | -227.57M | -218.21M | -244.78M | -153.8M | -91.96M | -56.04M |
EBITDA | -178.27M | -257.62M | -224.57M | -214.91M | -226.02M | -150.3M | -89.36M | -54.14M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約